Navigation Links
Patients Say MPM Medical's Regenecare Gel Significantly Reduced the Itching and Pain of Skin Rashes Triggered by Anti-Cancer Drugs
Date:3/30/2009

IRVING, Texas, March 30 /PRNewswire-FirstCall/ -- Patients undergoing cancer treatment reported that using Regenecare hydrogel significantly reduced the pain and itching associated with the sometimes-severe skin rashes caused by anti-cancer drugs.

Conducted by the Western University of Health Sciences, the study substantiated the findings of nine previous clinical trials recognizing Regenecare for its pain-relieving and wound-healing benefits. Manufactured by MPM Medical, Inc., Regenecare is the only wound and pain management product of its kind on the market.

"Pain management is one of the most-significant issues facing healthcare today," said MPM President Paul Miller. "Many patients stop or forgo treatment because they cannot tolerate the itching and painful side effects often associated with these treatments. Regenecare is a unique hydrogel whose benefits are substantiated by science and validated by patients."

The six-week study followed 13 patients who were taking a class of anti-cancer drugs that, while effective, often produce a severe rash on a patient's face, neck, back and legs. If scratched, these rashes can become infected. Patients reported "significant reduction" of itching when using Regenecare, according to the study.

Researchers credit Regenecare's unparalleled pain relief and wound healing to its formulation of 2% lidocaine (for local pain management), marine collagen (to promote tissue formation), Aloe vera (to enhance circulation and to promote emollient effect) and sodium alginate (to absorb exudates).

"Pain is the leading cause of disability in the United States and is straining our healthcare system," according to the National Pain Care Policy Act of 2008 (H.R. 2994). Among other things, the pending legislation seeks "to improve the assessment, understanding and treatment of pain."

MPM offers Regenecare HA as an over-the-counter version of the prescription Regenecare. Regenecare HA has the same formulation, but it also contains hyaluronic acid, which enhances moisture and healing. Consumers may purchase Regenecare and other MPM products online at www.MPMmedicalinc.com.

About RBC Life SciencesRBC Life Sciences (OTC Bulletin Board: RBCL) develops, manufactures and markets high-quality nutritional supplements and personal care products to a growing population of consumers seeking wellness and a healthy lifestyle. Under its MPM Medical, Inc., brand, RBC Life Sciences also develops and markets to health care professionals in the United States proprietary prescription and nonprescription products for advanced wound care and pain management. All products are tested for quality assurance in-house, and by outside independent laboratories, to comply with regulations in the U.S. and in more than thirty countries in which the products are distributed. For more information, visit the Company's Web site at www.rbclifesciences.com.

The statements above, other than statements of historical fact, may be forward-looking. Actual events will be dependent upon a number of factors and risks including, but not limited to, changes in plans by the Company's management, delays or problems in production, changes in the regulatory process, changes in market trends, and a number of other factors and risks described from time to time in the Company's filings with the Securities and Exchange Commission.


'/>"/>
SOURCE RBC Life Sciences
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. DaVitas IMPACT Program Reduces Mortality for New Dialysis Patients
2. Hormone Reduces Mortality in Heart Patients With High BP
3. LegalView Informs Baxter Heparin Patients of New Testing Standards for Blood Thinner Following Deaths From Previous Contamination
4. Patients Bill of Rights Too Tough to Read
5. Emmi + KidsHealth = Prescription for Informed and Involved Patients
6. Individualized stroke treatment available for patients, though underutilized
7. External focus improves postural stability in patients with Parkinsons disease
8. Northeast Ohio's Center for Orthopedics Saves Patients Time with Online Next-Day Appointment Scheduling for its Open Cast Room
9. TMA Physicians and Legislators: Patients Have a Right to Know
10. Music Can Help Restore Stroke Patients Sight
11. Drug Combo Helps Larynx Cancer Patients Preserve Voice Box
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2017)... ... July 28, 2017 , ... Mirror Mirror Beauty Boutique was ... the most successful CoolSculpting practices across the country are annually honored. This marks ... coveted Diamond Level status, the highest ranking possible. , CoolSculpting is a ...
(Date:7/28/2017)... LAND O' LAKES, FL (PRWEB) , ... July ... ... Acute Care Hospital (LTACH) received the Vapotherm Center of Excellence designation for use ... is the highest recognition a facility can receive from Vapotherm, and signifies that ...
(Date:7/28/2017)... ... July 28, 2017 , ... Nominated for ... Chain Partners for 2017. MEBC received numerous client nominations from customers who ... Berger, SupplyChainBrain’s publisher, says “For 15 years running, SupplyChainBrain has published our much-anticipated ...
(Date:7/28/2017)... , ... July 28, 2017 , ... James M. Maisel, ... to have chaired the Epidemiology and Prevention of Diabetes section at the 5th World ... also chairman of Retina Group of New York and recipient of the Juvenile Diabetes ...
(Date:7/28/2017)... ... 28, 2017 , ... The United States Department of Agriculture ... programs. , Right now the most public debate is over the Supplemental Nutrition ... are under consideration, including WIC (Women, Infants, and Children), which is the country’s ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ( ... development of oral drug delivery systems, announced today that ... to schedule an End-of-Phase II meeting with Oramed for ... insulin capsule ORMD-0801 in the treatment of type 2 ... endpoints by indicating a statistically significant lowering of glucose ...
(Date:7/10/2017)... 10, 2017 The Institute for In Vitro ... the recipient of a VITROCELL® inhalation exposure system thanks ... Consortium. The device, which is designed to replace animals ... lung cells to airborne test materials in an environment ... VITROCELL® system for testing combustible tobacco products, as well ...
(Date:7/10/2017)... , July 10, 2017  The tenth annual ... Boston, MA at the Sheraton Boston ... and unparalleled access to global decision makers and innovative ... 800+ life science leaders during two impactful days. BioPharm ... provides delegates with additional networking opportunities with 4,500+ life ...
Breaking Medicine Technology: